Creatine, Creatinine, and the Rehabilitation Patient

Student Handouts and Nephrology Primer · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

A creatinine rise after creatine use needs evaluation; it is neither automatic proof of AKI nor automatic evidence of safety.

More creatinine production can change an estimate. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

More creatinine production can change an estimate. Creatine intake — Take a product-specific history; Muscle metabolism — Creatinine generation can change; Serum creatinine — A concentration used in eGFR estimation; Independent injury assessment — Urine findings, trajectory and another marker when useful. A creatinine change is not automatically kidney injury; do not ignore independent injury clues either. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Separate the molecules

Creatine participates in muscle energy buffering; creatinine is a breakdown product used in GFR estimates. Supplement use, greater muscle mass, and recent intense exercise can raise creatinine independently of filtration.

Take a product-specific history

Record the exact product, dose, start date, coingredients, exercise load, hydration, and other supplements. Ask about NSAIDs, anabolic agents, and recent illness rather than assuming a single-ingredient product.

Check for true injury

Compare baseline creatinine and urine output; check urinalysis and electrolytes. Muscle pain, weakness, dark urine, or an extreme exertional event should prompt assessment for rhabdomyolysis, including creatine kinase when indicated.

Resolve a discordant estimate

If creatinine-based eGFR conflicts with the clinical picture, consider cystatin C or a combined estimate. Neither a supplement history nor one reassuring alternative marker replaces evaluation of persistent or symptomatic deterioration.

Discuss benefit in the studied population

Strength benefits are usually evaluated with resistance training in defined populations. Evidence in healthy adults should not be treated as proof of safety in recent AKI, established CKD, pregnancy, or complex illness.

Worked example

An asymptomatic trainee has a small creatinine rise after beginning creatine, stable urine findings, and no loss of urine output. Review exposure and repeat appropriate assessment before applying a CKD label; investigate any concerning trend rather than dismissing it.

Continue learning